Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Background:

• Mitogen-activated protein kinase (MAPK) pathway regulates cell proliferation and survival.
• Alternative splicing of the MKNK2 gene produces Mnk2a and Mnk2b isoforms with distinct functions.
• The translation initiation factor eIF4E is a key regulator of protein synthesis.

Purpose of the Study:

• To investigate the distinct roles of Mnk2a and Mnk2b isoforms in cancer.
• To elucidate the mechanism of Mnk2a's tumor suppressive activity.
• To determine the clinical relevance of Mnk2a downregulation in human tumors.

Main Methods:

• Analysis of gene expression in human tumor samples.
• Western blotting and co-immunoprecipitation to study protein interactions.
• Cellular localization studies using immunofluorescence.
• Functional assays for cell death and transformation.

Main Results:

• Mnk2a is downregulated in breast, lung, and colon tumors, acting as a tumor suppressor.
• Mnk2a interacts with, phosphorylates, and activates p38α-MAPK, promoting nuclear translocation.
• Mnk2b is pro-oncogenic, enhancing eIF4E phosphorylation without activating p38α-MAPK.
• Mnk2a's tumor suppressive activity requires its nuclear colocalization with p38α-MAPK.

Conclusions:

• Mnk2a acts as a tumor suppressor by activating p38α-MAPK signaling in the nucleus.
• Downregulation of Mnk2a via alternative splicing is a mechanism contributing to tumorigenesis.
• Loss of Mnk2a function is implicated in breast, lung, and colon cancer development.